Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients
2003 ◽
Vol 31
(8)
◽
pp. 655-661
◽
2015 ◽
Vol 51
(2)
◽
pp. 227-231
◽
2013 ◽
Vol 28
(2)
◽
pp. 220
◽
2002 ◽
Vol 17
(4)
◽
pp. 537
◽
2012 ◽
Vol 27
(4)
◽
pp. 363
◽
2019 ◽
Vol 121
(10)
◽
pp. 894-895
◽